Gardasil Approved in Europe for the Prevention of Anal Cancer

The European Commission granted a new indication for GardasilĀ®, for the prevention of anal cancer and anal precancerous lesions caused by specific oncogenic HPV types in both females and males June 18, 2014 Sanofi Pasteur MSD announced today that the European Commission has granted marketing authorisation for the use of Gardasil for the prevention of anal precancerous lesions and anal …